Chemicals

Showing 33151–33300 of 41137 results

  • Prostaglandin F2β (PGF2β) (tromethamine salt) is a derivative of PGF2β (Item No. 16410) with increased water solubility. PGF2β is the 9β-hydroxy stereoisomer of PGF2α (Item No. 16010). It is much less active than PGF2α in antifertility and bronchoconstrictor activities.{1925,2121,633} PGF2β exhibits bronchodilating activity in guinea pigs and cats and antagonizes the bronchoconstrictor activity of PGF2α.{633}  

     

    Brand:
    Cayman
    SKU:-

    Out of stock

  • Prostaglandin F2β (PGF2β) (tromethamine salt) is a derivative of PGF2β (Item No. 16410) with increased water solubility. PGF2β is the 9β-hydroxy stereoisomer of PGF2α (Item No. 16010). It is much less active than PGF2α in antifertility and bronchoconstrictor activities.{1925,2121,633} PGF2β exhibits bronchodilating activity in guinea pigs and cats and antagonizes the bronchoconstrictor activity of PGF2α.{633}  

     

    Brand:
    Cayman
    SKU:-

    Out of stock

  • Prostaglandin F2β (PGF2β) (tromethamine salt) is a derivative of PGF2β (Item No. 16410) with increased water solubility. PGF2β is the 9β-hydroxy stereoisomer of PGF2α (Item No. 16010). It is much less active than PGF2α in antifertility and bronchoconstrictor activities.{1925,2121,633} PGF2β exhibits bronchodilating activity in guinea pigs and cats and antagonizes the bronchoconstrictor activity of PGF2α.{633}  

     

    Brand:
    Cayman
    SKU:-

    Out of stock

  • Prostaglandin F2β (PGF2β) is the 9β-hydroxy stereoisomer of PGF2α (Item Nos. 16010 | 10007221). It is much less active than PGF2α in antifertility and bronchoconstrictor activities.{1925,2121,633} PGF2β exhibits bronchodilating activity in guinea pigs and cats and antagonizes the bronchoconstrictor activity of PGF2α.{633} PGF2β MaxSpec® standard is a quantitative grade standard of PGF2β (Item No. 16410) that has been prepared specifically for mass spectrometry or any application where quantitative reproducibility is required. The solution has been prepared gravimetrically and is supplied in a deactivated glass ampule sealed under argon. The concentration was verified by comparison to an independently prepared calibration standard. This PGF2β MaxSpec® standard is guaranteed to meet identity, purity, stability, and concentration specifications and is provided with a batch-specific certificate of analysis. Ongoing stability testing is performed to ensure the concentration remains accurate throughout the shelf life of the product. Note: The amount of solution added to the vial is in excess of the listed amount. Therefore, it is necessary to accurately measure volumes for preparation of calibration standards. Follow recommended storage and handling conditions to maintain product quality.  

     

    Brand:
    Cayman
    SKU:10007232 - 100 µg

    Available on backorder

  • PGF3α is a COX product of EPA. The biosynthesis of PGF3α from EPA was demonstrated in vitro in human and rabbit ocular tissues.{1145} It has only 25% affinity at the ovine luteal FP receptor compared to PGF2α.{2058}  

     

    Brand:
    Cayman
    SKU:-

    Out of stock

  • PGF3α is a COX product of EPA. The biosynthesis of PGF3α from EPA was demonstrated in vitro in human and rabbit ocular tissues.{1145} It has only 25% affinity at the ovine luteal FP receptor compared to PGF2α.{2058}  

     

    Brand:
    Cayman
    SKU:-

    Out of stock

  • PGF3α is a COX product of EPA. The biosynthesis of PGF3α from EPA was demonstrated in vitro in human and rabbit ocular tissues.{1145} It has only 25% affinity at the ovine luteal FP receptor compared to PGF2α.{2058}  

     

    Brand:
    Cayman
    SKU:-

    Out of stock

  • PGF3α is a COX product of EPA. The biosynthesis of PGF3α from EPA was demonstrated in vitro in human and rabbit ocular tissues.{1145} It has only 25% affinity at the ovine luteal FP receptor compared to PGF2α.{2058}  

     

    Brand:
    Cayman
    SKU:-

    Out of stock

  • Prostaglandin G2 (PGG2) is the first intermediate in the COX pathway which is stable enough to be isolated and characterized.{499} It is the C-15 hydroperoxide of PGH2. Under normal conditions, PGG2 is quickly metabolized by the peroxidase activity intrinsic to both COX-1 and -2 to give PGH2, which serves as the key precursor to the 2-series PGs and thromboxanes.{499,759}  

     

    Brand:
    Cayman
    SKU:-

    Out of stock

  • Prostaglandin G2 (PGG2) is the first intermediate in the COX pathway which is stable enough to be isolated and characterized.{499} It is the C-15 hydroperoxide of PGH2. Under normal conditions, PGG2 is quickly metabolized by the peroxidase activity intrinsic to both COX-1 and -2 to give PGH2, which serves as the key precursor to the 2-series PGs and thromboxanes.{499,759}  

     

    Brand:
    Cayman
    SKU:-

    Out of stock

  • Prostaglandin G2 (PGG2) is the first intermediate in the COX pathway which is stable enough to be isolated and characterized.{499} It is the C-15 hydroperoxide of PGH2. Under normal conditions, PGG2 is quickly metabolized by the peroxidase activity intrinsic to both COX-1 and -2 to give PGH2, which serves as the key precursor to the 2-series PGs and thromboxanes.{499,759}  

     

    Brand:
    Cayman
    SKU:-

    Out of stock

  • Prostaglandin G2 (PGG2) is the first intermediate in the COX pathway which is stable enough to be isolated and characterized.{499} It is the C-15 hydroperoxide of PGH2. Under normal conditions, PGG2 is quickly metabolized by the peroxidase activity intrinsic to both COX-1 and -2 to give PGH2, which serves as the key precursor to the 2-series PGs and thromboxanes.{499,759}  

     

    Brand:
    Cayman
    SKU:-

    Out of stock

  • Prostaglandin H1 (PGH1) is a COX metabolite of DGLA and is the precursor to all 1-series PGs and thromboxanes. PGH1 is a suicide inhibitor of platelet thromboxane synthase with a Ki of 28 µM.{49}  

     

    Brand:
    Cayman
    SKU:-

    Out of stock

  • Prostaglandin H1 (PGH1) is a COX metabolite of DGLA and is the precursor to all 1-series PGs and thromboxanes. PGH1 is a suicide inhibitor of platelet thromboxane synthase with a Ki of 28 µM.{49}  

     

    Brand:
    Cayman
    SKU:-

    Out of stock

  • Prostaglandin H1 (PGH1) is a COX metabolite of DGLA and is the precursor to all 1-series PGs and thromboxanes. PGH1 is a suicide inhibitor of platelet thromboxane synthase with a Ki of 28 µM.{49}  

     

    Brand:
    Cayman
    SKU:-

    Out of stock

  • Prostaglandin H1 (PGH1) is a COX metabolite of DGLA and is the precursor to all 1-series PGs and thromboxanes. PGH1 is a suicide inhibitor of platelet thromboxane synthase with a Ki of 28 µM.{49}  

     

    Brand:
    Cayman
    SKU:-

    Out of stock

  • Prostaglandin H2 (PGH2) was first isolated from incubations of arachidonic acid with ovine seminal vesicle microsomes, and was described as a potent vasoconstrictor.{365} PGH2 is the precursor for all 2-series PGs and thromboxanes (TXs),{187} and is a TP receptor agonist which irreversibly aggregates human platelets at 50-100 ng/ml.  

     

    Brand:
    Cayman
    SKU:-

    Out of stock

  • Prostaglandin H2 (PGH2) was first isolated from incubations of arachidonic acid with ovine seminal vesicle microsomes, and was described as a potent vasoconstrictor.{365} PGH2 is the precursor for all 2-series PGs and thromboxanes (TXs),{187} and is a TP receptor agonist which irreversibly aggregates human platelets at 50-100 ng/ml.  

     

    Brand:
    Cayman
    SKU:-

    Out of stock

  • Prostaglandin H2 (PGH2) was first isolated from incubations of arachidonic acid with ovine seminal vesicle microsomes, and was described as a potent vasoconstrictor.{365} PGH2 is the precursor for all 2-series PGs and thromboxanes (TXs),{187} and is a TP receptor agonist which irreversibly aggregates human platelets at 50-100 ng/ml.  

     

    Brand:
    Cayman
    SKU:-

    Out of stock

  • Prostaglandin H2 (PGH2) was first isolated from incubations of arachidonic acid with ovine seminal vesicle microsomes, and was described as a potent vasoconstrictor.{365} PGH2 is the precursor for all 2-series PGs and thromboxanes (TXs),{187} and is a TP receptor agonist which irreversibly aggregates human platelets at 50-100 ng/ml.  

     

    Brand:
    Cayman
    SKU:-

    Out of stock

  • Prostaglandin I2 (PGI2) is an unstable cyclooxygenase metabolite detected first in vascular endothelial cells.{502,443,933} It elevates platelet cAMP and is a potent vasodilator and inhibitor of human platelet aggregation with an IC50 of 5 nM.{4375} PGI2 is stable in basic buffers (pH=8), but it is rapidly hydrolyzed to 6-keto PGF1α in neutral or acidic solutions. The half-life is short both in vivo and in vitro, ranging from 30 seconds to a few minutes. PGI2 is administered by continuous infusion in humans for the treatment of idiopathic pulmonary hypertension.{5466}  

     

    Brand:
    Cayman
    SKU:-

    Available on backorder

  • Prostaglandin I2 (PGI2) is an unstable cyclooxygenase metabolite detected first in vascular endothelial cells.{502,443,933} It elevates platelet cAMP and is a potent vasodilator and inhibitor of human platelet aggregation with an IC50 of 5 nM.{4375} PGI2 is stable in basic buffers (pH=8), but it is rapidly hydrolyzed to 6-keto PGF1α in neutral or acidic solutions. The half-life is short both in vivo and in vitro, ranging from 30 seconds to a few minutes. PGI2 is administered by continuous infusion in humans for the treatment of idiopathic pulmonary hypertension.{5466}  

     

    Brand:
    Cayman
    SKU:-

    Available on backorder

  • Prostaglandin I2 (PGI2) is an unstable cyclooxygenase metabolite detected first in vascular endothelial cells.{502,443,933} It elevates platelet cAMP and is a potent vasodilator and inhibitor of human platelet aggregation with an IC50 of 5 nM.{4375} PGI2 is stable in basic buffers (pH=8), but it is rapidly hydrolyzed to 6-keto PGF1α in neutral or acidic solutions. The half-life is short both in vivo and in vitro, ranging from 30 seconds to a few minutes. PGI2 is administered by continuous infusion in humans for the treatment of idiopathic pulmonary hypertension.{5466}  

     

    Brand:
    Cayman
    SKU:-

    Available on backorder

  • Prostaglandin I2 (PGI2) is an unstable cyclooxygenase metabolite detected first in vascular endothelial cells.{502,443,933} It elevates platelet cAMP and is a potent vasodilator and inhibitor of human platelet aggregation with an IC50 of 5 nM.{4375} PGI2 is stable in basic buffers (pH=8), but it is rapidly hydrolyzed to 6-keto PGF1α in neutral or acidic solutions. The half-life is short both in vivo and in vitro, ranging from 30 seconds to a few minutes. PGI2 is administered by continuous infusion in humans for the treatment of idiopathic pulmonary hypertension.{5466}  

     

    Brand:
    Cayman
    SKU:-

    Available on backorder

  • PGI3 is synthesized from EPA by COX and PGI synthase. PGI3 has a short in vivo half-life and is hydrolyzed to Δ17-6-keto PGF1α. The platelet and vascular activity of PGI3 is equivalent to that of PGI2.{1529,697}  

     

    Brand:
    Cayman
    SKU:-

    Available on backorder

  • PGI3 is synthesized from EPA by COX and PGI synthase. PGI3 has a short in vivo half-life and is hydrolyzed to Δ17-6-keto PGF1α. The platelet and vascular activity of PGI3 is equivalent to that of PGI2.{1529,697}  

     

    Brand:
    Cayman
    SKU:-

    Available on backorder

  • PGI3 is synthesized from EPA by COX and PGI synthase. PGI3 has a short in vivo half-life and is hydrolyzed to Δ17-6-keto PGF1α. The platelet and vascular activity of PGI3 is equivalent to that of PGI2.{1529,697}  

     

    Brand:
    Cayman
    SKU:-

    Available on backorder

  • PGI3 is synthesized from EPA by COX and PGI synthase. PGI3 has a short in vivo half-life and is hydrolyzed to Δ17-6-keto PGF1α. The platelet and vascular activity of PGI3 is equivalent to that of PGI2.{1529,697}  

     

    Brand:
    Cayman
    SKU:-

    Available on backorder

  • Prostaglandin J2 (PGJ2) is formed from PGD2 by the elimination of the C-9 hydroxyl group, a process which is accelerated by the presence of albumin.{1742} PGJ2 inhibits platelet aggregation with an IC50 of about 5-10 nM.{1139,504} PGJ2 has antimitotic and antiproliferative effects on a variety of cultured normal cells and tumor cell lines.{870} However, this activity has been attributed to further metabolites of PGJ2 and not the parent compound itself.  

     

    Brand:
    Cayman
    SKU:-

    Available on backorder

  • Prostaglandin J2 (PGJ2) is formed from PGD2 by the elimination of the C-9 hydroxyl group, a process which is accelerated by the presence of albumin.{1742} PGJ2 inhibits platelet aggregation with an IC50 of about 5-10 nM.{1139,504} PGJ2 has antimitotic and antiproliferative effects on a variety of cultured normal cells and tumor cell lines.{870} However, this activity has been attributed to further metabolites of PGJ2 and not the parent compound itself.  

     

    Brand:
    Cayman
    SKU:-

    Available on backorder

  • Prostaglandin J2 (PGJ2) is formed from PGD2 by the elimination of the C-9 hydroxyl group, a process which is accelerated by the presence of albumin.{1742} PGJ2 inhibits platelet aggregation with an IC50 of about 5-10 nM.{1139,504} PGJ2 has antimitotic and antiproliferative effects on a variety of cultured normal cells and tumor cell lines.{870} However, this activity has been attributed to further metabolites of PGJ2 and not the parent compound itself.  

     

    Brand:
    Cayman
    SKU:-

    Available on backorder

  • Prostaglandin J2 (PGJ2) is formed from PGD2 by the elimination of the C-9 hydroxyl group, a process which is accelerated by the presence of albumin.{1742} PGJ2 inhibits platelet aggregation with an IC50 of about 5-10 nM.{1139,504} PGJ2 has antimitotic and antiproliferative effects on a variety of cultured normal cells and tumor cell lines.{870} However, this activity has been attributed to further metabolites of PGJ2 and not the parent compound itself.  

     

    Brand:
    Cayman
    SKU:-

    Available on backorder

  • PGK1 is the 9,11-diketone formed by the oxidation of PGE1 or PGD1. Whether this compound exists biologically is uncertain; it is known to be resistant to metabolism by 15-hydroxy PGDH in vitro.{1789} In an intact porcine model of balloon angioplasty restenosis, PGK1 was equivalent in activity and potency to PGE1.{6703}  

     

    Brand:
    Cayman
    SKU:-

    Available on backorder

  • PGK1 is the 9,11-diketone formed by the oxidation of PGE1 or PGD1. Whether this compound exists biologically is uncertain; it is known to be resistant to metabolism by 15-hydroxy PGDH in vitro.{1789} In an intact porcine model of balloon angioplasty restenosis, PGK1 was equivalent in activity and potency to PGE1.{6703}  

     

    Brand:
    Cayman
    SKU:-

    Available on backorder

  • PGK1 is the 9,11-diketone formed by the oxidation of PGE1 or PGD1. Whether this compound exists biologically is uncertain; it is known to be resistant to metabolism by 15-hydroxy PGDH in vitro.{1789} In an intact porcine model of balloon angioplasty restenosis, PGK1 was equivalent in activity and potency to PGE1.{6703}  

     

    Brand:
    Cayman
    SKU:-

    Available on backorder

  • PGK1 is the 9,11-diketone formed by the oxidation of PGE1 or PGD1. Whether this compound exists biologically is uncertain; it is known to be resistant to metabolism by 15-hydroxy PGDH in vitro.{1789} In an intact porcine model of balloon angioplasty restenosis, PGK1 was equivalent in activity and potency to PGE1.{6703}  

     

    Brand:
    Cayman
    SKU:-

    Available on backorder

  • Prostaglandin K2 (PGK2) is the 9,11-diketone formed by the oxidation of PGE2 or PGD2. Whether this compound exists biologically is uncertain; it is known to be resistant to metabolism by 15-hydroxy PGDH in vitro.{1789}  

     

    Brand:
    Cayman
    SKU:-

    Available on backorder

  • Prostaglandin K2 (PGK2) is the 9,11-diketone formed by the oxidation of PGE2 or PGD2. Whether this compound exists biologically is uncertain; it is known to be resistant to metabolism by 15-hydroxy PGDH in vitro.{1789}  

     

    Brand:
    Cayman
    SKU:-

    Available on backorder

  • Prostaglandin K2 (PGK2) is the 9,11-diketone formed by the oxidation of PGE2 or PGD2. Whether this compound exists biologically is uncertain; it is known to be resistant to metabolism by 15-hydroxy PGDH in vitro.{1789}  

     

    Brand:
    Cayman
    SKU:-

    Available on backorder

  • Prostaglandin K2 (PGK2) is the 9,11-diketone formed by the oxidation of PGE2 or PGD2. Whether this compound exists biologically is uncertain; it is known to be resistant to metabolism by 15-hydroxy PGDH in vitro.{1789}  

     

    Brand:
    Cayman
    SKU:-

    Available on backorder

  • Activation of latent reservoirs of HIV-infected cells is a treatment strategy designed to reduce viral load and eliminate the perpetuation of retroviral infection. Prostratin is a non-tumor promoting phorbol ester that potently induces HIV-1 reactivation in latent reservoirs of infected Jurkat-LAT-GFP cells with an IC50 value of ~0.5 µM.{17117} Originally, prostratin was isolated from plant sources including P. prostrata, E. cornigera, and H. nutans. {15812} The effects of prostratin are mediated through activation of NF-κB via protein kinase C and by downregulation of HIV-1 receptor CD4 expression and its co-receptors CXCR4 and CCR5.{17116,17118,17119}  

     

    Brand:
    Cayman
    SKU:10272 - 1 mg

    Available on backorder

  • Activation of latent reservoirs of HIV-infected cells is a treatment strategy designed to reduce viral load and eliminate the perpetuation of retroviral infection. Prostratin is a non-tumor promoting phorbol ester that potently induces HIV-1 reactivation in latent reservoirs of infected Jurkat-LAT-GFP cells with an IC50 value of ~0.5 µM.{17117} Originally, prostratin was isolated from plant sources including P. prostrata, E. cornigera, and H. nutans. {15812} The effects of prostratin are mediated through activation of NF-κB via protein kinase C and by downregulation of HIV-1 receptor CD4 expression and its co-receptors CXCR4 and CCR5.{17116,17118,17119}  

     

    Brand:
    Cayman
    SKU:10272 - 10 mg

    Available on backorder

  • Activation of latent reservoirs of HIV-infected cells is a treatment strategy designed to reduce viral load and eliminate the perpetuation of retroviral infection. Prostratin is a non-tumor promoting phorbol ester that potently induces HIV-1 reactivation in latent reservoirs of infected Jurkat-LAT-GFP cells with an IC50 value of ~0.5 µM.{17117} Originally, prostratin was isolated from plant sources including P. prostrata, E. cornigera, and H. nutans. {15812} The effects of prostratin are mediated through activation of NF-κB via protein kinase C and by downregulation of HIV-1 receptor CD4 expression and its co-receptors CXCR4 and CCR5.{17116,17118,17119}  

     

    Brand:
    Cayman
    SKU:10272 - 5 mg

    Available on backorder

  • Activation of latent reservoirs of HIV-infected cells is a treatment strategy designed to reduce viral load and eliminate the perpetuation of retroviral infection. Prostratin is a non-tumor promoting phorbol ester that potently induces HIV-1 reactivation in latent reservoirs of infected Jurkat-LAT-GFP cells with an IC50 value of ~0.5 µM.{17117} Originally, prostratin was isolated from plant sources including P. prostrata, E. cornigera, and H. nutans. {15812} The effects of prostratin are mediated through activation of NF-κB via protein kinase C and by downregulation of HIV-1 receptor CD4 expression and its co-receptors CXCR4 and CCR5.{17116,17118,17119}  

     

    Brand:
    Cayman
    SKU:10272 - 500 µg

    Available on backorder

  • proTAME is a cell-permeable prodrug form of N-4-tosyl-L-arginine methyl ester (TAME; Item No. 17550), an inhibitor of the anaphase-promoting complex/cyclosome (APC/C), that is converted to TAME by intracellular esterases.{28533,36286} proTAME (12 μM) blocks association of APC/C with the activator CDH1 and inhibits degradation of APC/C substrates in HeLa cells.{28533} It induces mitotic arrest in metaphase followed by cell death in synchronized HeLa H2B-GFP cells when used at a concentration of 12 μM. It also increases mitotic duration in asynchronous HeLa H2B-GFP cells at a concentration of 4 μM, an effect that is enhanced by knockdown of the APC/C co-activator CDC20. proTAME decreases the viability of several laboratory and primary patient-derived human multiple myeloma (MM) cell lines (IC50s = 2.8-20.3 μM) and increases apoptosis in RPMI-8226, LP-1, NCI-H929, and U266 MM cells when used at a concentration of 12 μM.{36286}  

     

    Brand:
    Cayman
    SKU:25835 - 1 mg

    Available on backorder

  • Protectin D1 is a specialized pro-resolving mediator (SPM) synthesized from docosahexaenoic acid (DHA; Item No. 90310).{38180} DHA is oxidized to 16S,17S-epoxy-protectin, which is converted to protectin D1 enzymatically. Protectin D1 increases phagocytosis of apoptotic polymorphonuclear leukocytes (PMNs) by macrophages in a non-phlogistic manner and is generated in vitro during macrophage-apoptotic interactions.{14972} It enhances phagocytosis in mice after 24 hours, but not at the initiation or peak of inflammation. It also decreases PMN infiltration in a zymosan-induced mouse model of inflammation when administered at a dose of 300 ng per animal. Protectin D1 (200 µg, i.v.) inhibits increases in neutrophil counts in bronchoalveolar fluid (BALF) and lung myeloperoxidase activity in a mouse model of pulmonary injury and inflammation induced by intratracheal LPS instillation.{48017} It also decreases pulmonary edema and promotes neutrophil apoptosis in BALF.  

     

    Brand:
    Cayman
    SKU:10010390 - 10 µg

    Available on backorder

  • Protectin D1 is a specialized pro-resolving mediator (SPM) synthesized from docosahexaenoic acid (DHA; Item No. 90310).{38180} DHA is oxidized to 16S,17S-epoxy-protectin, which is converted to protectin D1 enzymatically. Protectin D1 increases phagocytosis of apoptotic polymorphonuclear leukocytes (PMNs) by macrophages in a non-phlogistic manner and is generated in vitro during macrophage-apoptotic interactions.{14972} It enhances phagocytosis in mice after 24 hours, but not at the initiation or peak of inflammation. It also decreases PMN infiltration in a zymosan-induced mouse model of inflammation when administered at a dose of 300 ng per animal. Protectin D1 (200 µg, i.v.) inhibits increases in neutrophil counts in bronchoalveolar fluid (BALF) and lung myeloperoxidase activity in a mouse model of pulmonary injury and inflammation induced by intratracheal LPS instillation.{48017} It also decreases pulmonary edema and promotes neutrophil apoptosis in BALF.  

     

    Brand:
    Cayman
    SKU:10010390 - 100 µg

    Available on backorder

  • Protectin D1 is a specialized pro-resolving mediator (SPM) synthesized from docosahexaenoic acid (DHA; Item No. 90310).{38180} DHA is oxidized to 16S,17S-epoxy-protectin, which is converted to protectin D1 enzymatically. Protectin D1 increases phagocytosis of apoptotic polymorphonuclear leukocytes (PMNs) by macrophages in a non-phlogistic manner and is generated in vitro during macrophage-apoptotic interactions.{14972} It enhances phagocytosis in mice after 24 hours, but not at the initiation or peak of inflammation. It also decreases PMN infiltration in a zymosan-induced mouse model of inflammation when administered at a dose of 300 ng per animal. Protectin D1 (200 µg, i.v.) inhibits increases in neutrophil counts in bronchoalveolar fluid (BALF) and lung myeloperoxidase activity in a mouse model of pulmonary injury and inflammation induced by intratracheal LPS instillation.{48017} It also decreases pulmonary edema and promotes neutrophil apoptosis in BALF.  

     

    Brand:
    Cayman
    SKU:10010390 - 25 µg

    Available on backorder

  • Protectin D1 is a specialized pro-resolving mediator (SPM) synthesized from docosahexaenoic acid (DHA; Item No. 90310).{38180} DHA is oxidized to 16S,17S-epoxy-protectin, which is converted to protectin D1 enzymatically. Protectin D1 increases phagocytosis of apoptotic polymorphonuclear leukocytes (PMNs) by macrophages in a non-phlogistic manner and is generated in vitro during macrophage-apoptotic interactions.{14972} It enhances phagocytosis in mice after 24 hours, but not at the initiation or peak of inflammation. It also decreases PMN infiltration in a zymosan-induced mouse model of inflammation when administered at a dose of 300 ng per animal. Protectin D1 (200 µg, i.v.) inhibits increases in neutrophil counts in bronchoalveolar fluid (BALF) and lung myeloperoxidase activity in a mouse model of pulmonary injury and inflammation induced by intratracheal LPS instillation.{48017} It also decreases pulmonary edema and promotes neutrophil apoptosis in BALF.  

     

    Brand:
    Cayman
    SKU:10010390 - 50 µg

    Available on backorder

  • Prothionamide is a bactericidal thioamide effective against M. tuberculosis (MIC = ~0.5 µg/ml), M. leprae (MIC = 0.8-1.6 mg/L), and M. avium.{26434} It forms a covalent adduct with nicotinamide adenine dinucleotide that inhibits mycobacterial InhA, the enoyl-acyl ACP reductase involved in mycolic acid biosynthesis, with a Ki value of 2 nM.{26434}  

     

    Brand:
    Cayman
    SKU:-
  • Prothionamide is a bactericidal thioamide effective against M. tuberculosis (MIC = ~0.5 µg/ml), M. leprae (MIC = 0.8-1.6 mg/L), and M. avium.{26434} It forms a covalent adduct with nicotinamide adenine dinucleotide that inhibits mycobacterial InhA, the enoyl-acyl ACP reductase involved in mycolic acid biosynthesis, with a Ki value of 2 nM.{26434}  

     

    Brand:
    Cayman
    SKU:-
  • Prothionamide is a bactericidal thioamide effective against M. tuberculosis (MIC = ~0.5 µg/ml), M. leprae (MIC = 0.8-1.6 mg/L), and M. avium.{26434} It forms a covalent adduct with nicotinamide adenine dinucleotide that inhibits mycobacterial InhA, the enoyl-acyl ACP reductase involved in mycolic acid biosynthesis, with a Ki value of 2 nM.{26434}  

     

    Brand:
    Cayman
    SKU:-
  • Prothionamide is a bactericidal thioamide effective against M. tuberculosis (MIC = ~0.5 µg/ml), M. leprae (MIC = 0.8-1.6 mg/L), and M. avium.{26434} It forms a covalent adduct with nicotinamide adenine dinucleotide that inhibits mycobacterial InhA, the enoyl-acyl ACP reductase involved in mycolic acid biosynthesis, with a Ki value of 2 nM.{26434}  

     

    Brand:
    Cayman
    SKU:-
  • Protocatechuic acid (PCA) is a dihydroxybenzoic acid phenolic compound found in many edible and medicinal plants. It is a major metabolite of antioxidant polyphenols found in green tea and demonstrates free radical scavenging capability in a 1,1-diphenyl-2-picrylhydrazyl radical scavenging activity assay (IC50 = 16.3 μM).{23837,23838} It is thought to possess anti-inflammatory, antihyperglycemic, neuroprotective, and anticancer activities. Dietary administration of PCA dose dependently inhibits in vitro chemical carcinogenesis and exerts pro-apoptotic and anti-proliferative effects in different tissues.{23839} In studies of tumor cell migration and invasion using mouse melanoma B16/F10 cells, PCA at 0.1-2 mM down-regulated the Ras/Akt/NF-κB pathway by targeting RhoB activation, leading to a reduction of MMP-mediated activity.{23836}  

     

    Brand:
    Cayman
    SKU:-
  • Protocatechuic acid (PCA) is a dihydroxybenzoic acid phenolic compound found in many edible and medicinal plants. It is a major metabolite of antioxidant polyphenols found in green tea and demonstrates free radical scavenging capability in a 1,1-diphenyl-2-picrylhydrazyl radical scavenging activity assay (IC50 = 16.3 μM).{23837,23838} It is thought to possess anti-inflammatory, antihyperglycemic, neuroprotective, and anticancer activities. Dietary administration of PCA dose dependently inhibits in vitro chemical carcinogenesis and exerts pro-apoptotic and anti-proliferative effects in different tissues.{23839} In studies of tumor cell migration and invasion using mouse melanoma B16/F10 cells, PCA at 0.1-2 mM down-regulated the Ras/Akt/NF-κB pathway by targeting RhoB activation, leading to a reduction of MMP-mediated activity.{23836}  

     

    Brand:
    Cayman
    SKU:-
  • Protocatechuic acid (PCA) is a dihydroxybenzoic acid phenolic compound found in many edible and medicinal plants. It is a major metabolite of antioxidant polyphenols found in green tea and demonstrates free radical scavenging capability in a 1,1-diphenyl-2-picrylhydrazyl radical scavenging activity assay (IC50 = 16.3 μM).{23837,23838} It is thought to possess anti-inflammatory, antihyperglycemic, neuroprotective, and anticancer activities. Dietary administration of PCA dose dependently inhibits in vitro chemical carcinogenesis and exerts pro-apoptotic and anti-proliferative effects in different tissues.{23839} In studies of tumor cell migration and invasion using mouse melanoma B16/F10 cells, PCA at 0.1-2 mM down-regulated the Ras/Akt/NF-κB pathway by targeting RhoB activation, leading to a reduction of MMP-mediated activity.{23836}  

     

    Brand:
    Cayman
    SKU:-
  • Protodioscin is a steroidal saponin first isolated from plants used in herbal remedies. It displays cytotoxicity against a range of cancer cells in vitro, including leukemia, colon cancer, and prostate cancer cells (GI50 ≤ 2 µM).{30394} Protodioscin, as a part of an extract from the plant T. terrestris, also improves sexual behavior parameters in rats.{30393}  

     

    Brand:
    Cayman
    SKU:11887 - 1 mg

    Available on backorder

  • Protodioscin is a steroidal saponin first isolated from plants used in herbal remedies. It displays cytotoxicity against a range of cancer cells in vitro, including leukemia, colon cancer, and prostate cancer cells (GI50 ≤ 2 µM).{30394} Protodioscin, as a part of an extract from the plant T. terrestris, also improves sexual behavior parameters in rats.{30393}  

     

    Brand:
    Cayman
    SKU:11887 - 10 mg

    Available on backorder

  • Protodioscin is a steroidal saponin first isolated from plants used in herbal remedies. It displays cytotoxicity against a range of cancer cells in vitro, including leukemia, colon cancer, and prostate cancer cells (GI50 ≤ 2 µM).{30394} Protodioscin, as a part of an extract from the plant T. terrestris, also improves sexual behavior parameters in rats.{30393}  

     

    Brand:
    Cayman
    SKU:11887 - 5 mg

    Available on backorder

  • Protodioscin is a steroidal saponin first isolated from plants used in herbal remedies. It displays cytotoxicity against a range of cancer cells in vitro, including leukemia, colon cancer, and prostate cancer cells (GI50 ≤ 2 µM).{30394} Protodioscin, as a part of an extract from the plant T. terrestris, also improves sexual behavior parameters in rats.{30393}  

     

    Brand:
    Cayman
    SKU:11887 - 50 mg

    Available on backorder

  • Protogracillin is a steroid saponin originally isolated from T. terrestris.{46012} It is cytotoxic to K562 cells (IC50 = 3.3 µM).{46013}  

     

    Brand:
    Cayman
    SKU:11893 - 1 mg

    Available on backorder

  • Protogracillin is a steroid saponin originally isolated from T. terrestris.{46012} It is cytotoxic to K562 cells (IC50 = 3.3 µM).{46013}  

     

    Brand:
    Cayman
    SKU:11893 - 10 mg

    Available on backorder

  • Protogracillin is a steroid saponin originally isolated from T. terrestris.{46012} It is cytotoxic to K562 cells (IC50 = 3.3 µM).{46013}  

     

    Brand:
    Cayman
    SKU:11893 - 5 mg

    Available on backorder

  • Protonitazene (hydrochloride) (Item No. 29381) is an analytical reference standard that is structurally similar to known opioids. This product is intended for research and forensic applications.  

     

    Brand:
    Cayman
    SKU:29381 - 1 mg

    Available on backorder

  • Protonitazene (hydrochloride) (Item No. 29381) is an analytical reference standard that is structurally similar to known opioids. This product is intended for research and forensic applications.  

     

    Brand:
    Cayman
    SKU:29381 - 5 mg

    Available on backorder

  • Protopine is an alkaloid found in Berberidaceae, Ranunculaceae, Rutaceae, Fumariaceae, and Papaveraceae with diverse biological activities.{41158} It inhibits platelet aggregation induced by ADP, arachidonic acid (Item Nos. 90010 | 90010.1 | 10006607), platelet-activating factor (PAF), and collagen in rabbit platelet-rich plasma at a concentration of 100 μM.{41159} Protopine inhibits contraction of isolated rat thoracic aorta induced by norepinephrine (Item No. 16673) and is a non-selective inhibitor of ICa, IK, IK1, and INa in guinea pig ventricular myocytes.{41160,41161} Protopine inhibits the growth of H. pylori with an MIC50 value of 100 μg/ml.{41162} It reduces growth of PC3 and DU145 prostate cancer cells in a dose-dependent manner via induction of mitotic cell cycle arrest.{41163} Protopine (0.005 mg/kg) increases latency to first seizure in a mouse model induced by pentylenetetrazole (Item No. 18682).{41164}  

     

    Brand:
    Cayman
    SKU:23366 - 1 mg

    Available on backorder

  • Protopine is an alkaloid found in Berberidaceae, Ranunculaceae, Rutaceae, Fumariaceae, and Papaveraceae with diverse biological activities.{41158} It inhibits platelet aggregation induced by ADP, arachidonic acid (Item Nos. 90010 | 90010.1 | 10006607), platelet-activating factor (PAF), and collagen in rabbit platelet-rich plasma at a concentration of 100 μM.{41159} Protopine inhibits contraction of isolated rat thoracic aorta induced by norepinephrine (Item No. 16673) and is a non-selective inhibitor of ICa, IK, IK1, and INa in guinea pig ventricular myocytes.{41160,41161} Protopine inhibits the growth of H. pylori with an MIC50 value of 100 μg/ml.{41162} It reduces growth of PC3 and DU145 prostate cancer cells in a dose-dependent manner via induction of mitotic cell cycle arrest.{41163} Protopine (0.005 mg/kg) increases latency to first seizure in a mouse model induced by pentylenetetrazole (Item No. 18682).{41164}  

     

    Brand:
    Cayman
    SKU:23366 - 500 µg

    Available on backorder

  • Protriptyline is a tricyclic antidepressant.{22877} It binds to the norepinephrine and serotonin (5-HT) transporters with Kd values of 1.41 and 19.6 nM, respectively. Protriptyline also binds to histamine H1, muscarinic acetylcholine, and α1-adrenergic receptors (Kds = 25, 25, and 130 nM, respectively).{25914} It inhibits norepinephrine uptake into rat whole brain and hypothalamic synaptosomes (IC50s = 12 and 0.55 μM, respectively) and 5-HT uptake into rat whole brain synaptosomes (IC50 = 5.5 μM).{54252} Protriptyline (1 mg/kg, i.v.) inhibits food-induced cataplexy in narcoleptic dogs.{46726} Formulations containing protriptyline have been used in the treatment of depression.  

     

    Brand:
    Cayman
    SKU:31179 - 10 mg

    Available on backorder

  • Protriptyline is a tricyclic antidepressant.{22877} It binds to the norepinephrine and serotonin (5-HT) transporters with Kd values of 1.41 and 19.6 nM, respectively. Protriptyline also binds to histamine H1, muscarinic acetylcholine, and α1-adrenergic receptors (Kds = 25, 25, and 130 nM, respectively).{25914} It inhibits norepinephrine uptake into rat whole brain and hypothalamic synaptosomes (IC50s = 12 and 0.55 μM, respectively) and 5-HT uptake into rat whole brain synaptosomes (IC50 = 5.5 μM).{54252} Protriptyline (1 mg/kg, i.v.) inhibits food-induced cataplexy in narcoleptic dogs.{46726} Formulations containing protriptyline have been used in the treatment of depression.  

     

    Brand:
    Cayman
    SKU:31179 - 25 mg

    Available on backorder

  • Protriptyline is a tricyclic antidepressant.{22877} It binds to the norepinephrine and serotonin (5-HT) transporters with Kd values of 1.41 and 19.6 nM, respectively. Protriptyline also binds to histamine H1, muscarinic acetylcholine, and α1-adrenergic receptors (Kds = 25, 25, and 130 nM, respectively).{25914} It inhibits norepinephrine uptake into rat whole brain and hypothalamic synaptosomes (IC50s = 12 and 0.55 μM, respectively) and 5-HT uptake into rat whole brain synaptosomes (IC50 = 5.5 μM).{54252} Protriptyline (1 mg/kg, i.v.) inhibits food-induced cataplexy in narcoleptic dogs.{46726} Formulations containing protriptyline have been used in the treatment of depression.  

     

    Brand:
    Cayman
    SKU:31179 - 5 mg

    Available on backorder

  • Protriptyline is a tricyclic antidepressant.{22877} It binds to the norepinephrine and serotonin (5-HT) transporters with Kd values of 1.41 and 19.6 nM, respectively. Protriptyline also binds to histamine H1, muscarinic acetylcholine, and α1-adrenergic receptors (Kds = 25, 25, and 130 nM, respectively).{25914} It inhibits norepinephrine uptake into rat whole brain and hypothalamic synaptosomes (IC50s = 12 and 0.55 μM, respectively) and 5-HT uptake into rat whole brain synaptosomes (IC50 = 5.5 μM).{54252} Protriptyline (1 mg/kg, i.v.) inhibits food-induced cataplexy in narcoleptic dogs.{46726} Formulations containing protriptyline have been used in the treatment of depression.  

     

    Brand:
    Cayman
    SKU:31179 - 50 mg

    Available on backorder

  • Proxyphylline is a methylxanthine derivative that has bronchodilatory actions.{32897} It has also been reported to have vasodilatory and cardiac stimulatory effects.{32898} Proxyphylline selectively antagonizes A1 adenosine receptors (Ki = 82 nM for bovine brain) versus A2 adenosine receptors (Ki = 850 µM for platelets).{29142} Proxyphylline has been mixed with Melilotus extract to generate a theo-esberiven product, which can have cardiovascular and anti-allodynia effects in mammals.{32898,32896}  

     

    Brand:
    Cayman
    SKU:20937 -

    Out of stock

  • Proxyphylline is a methylxanthine derivative that has bronchodilatory actions.{32897} It has also been reported to have vasodilatory and cardiac stimulatory effects.{32898} Proxyphylline selectively antagonizes A1 adenosine receptors (Ki = 82 nM for bovine brain) versus A2 adenosine receptors (Ki = 850 µM for platelets).{29142} Proxyphylline has been mixed with Melilotus extract to generate a theo-esberiven product, which can have cardiovascular and anti-allodynia effects in mammals.{32898,32896}  

     

    Brand:
    Cayman
    SKU:20937 -

    Out of stock

  • Proxyphylline is a methylxanthine derivative that has bronchodilatory actions.{32897} It has also been reported to have vasodilatory and cardiac stimulatory effects.{32898} Proxyphylline selectively antagonizes A1 adenosine receptors (Ki = 82 nM for bovine brain) versus A2 adenosine receptors (Ki = 850 µM for platelets).{29142} Proxyphylline has been mixed with Melilotus extract to generate a theo-esberiven product, which can have cardiovascular and anti-allodynia effects in mammals.{32898,32896}  

     

    Brand:
    Cayman
    SKU:20937 -

    Out of stock

  • Proxyphylline is a methylxanthine derivative that has bronchodilatory actions.{32897} It has also been reported to have vasodilatory and cardiac stimulatory effects.{32898} Proxyphylline selectively antagonizes A1 adenosine receptors (Ki = 82 nM for bovine brain) versus A2 adenosine receptors (Ki = 850 µM for platelets).{29142} Proxyphylline has been mixed with Melilotus extract to generate a theo-esberiven product, which can have cardiovascular and anti-allodynia effects in mammals.{32898,32896}  

     

    Brand:
    Cayman
    SKU:20937 -

    Out of stock

  • PRT060318 is a potent and selective inhibitor of spleen tyrosine kinase (Syk; IC50 = 4 nM).{39127,39128} It is selective, inhibiting 92% of Syk activity, while other kinases retain >70% activity, at a concentration of 50 nM in a panel of 270 kinases.{39128} PRT060318 inhibits convulxin-induced aggregation of human platelet-rich plasma (IC50 = 2.5 μM) in vitro and prevents thrombosis in a transgenic mouse model of heparin-induced thrombocytopenia. It induces chronic lymphocytic leukemia (CLL) B cell apoptosis and inhibits the secretion of chemokines CCL3, CCL4, and CXCL13.{39219} PRT060318 also inhibits CLL B cell chemotaxis and pseudoemperipolesis.  

     

    Brand:
    Cayman
    SKU:22476 -

    Out of stock

  • PRT060318 is a potent and selective inhibitor of spleen tyrosine kinase (Syk; IC50 = 4 nM).{39127,39128} It is selective, inhibiting 92% of Syk activity, while other kinases retain >70% activity, at a concentration of 50 nM in a panel of 270 kinases.{39128} PRT060318 inhibits convulxin-induced aggregation of human platelet-rich plasma (IC50 = 2.5 μM) in vitro and prevents thrombosis in a transgenic mouse model of heparin-induced thrombocytopenia. It induces chronic lymphocytic leukemia (CLL) B cell apoptosis and inhibits the secretion of chemokines CCL3, CCL4, and CXCL13.{39219} PRT060318 also inhibits CLL B cell chemotaxis and pseudoemperipolesis.  

     

    Brand:
    Cayman
    SKU:22476 -

    Out of stock

  • PRT060318 is a potent and selective inhibitor of spleen tyrosine kinase (Syk; IC50 = 4 nM).{39127,39128} It is selective, inhibiting 92% of Syk activity, while other kinases retain >70% activity, at a concentration of 50 nM in a panel of 270 kinases.{39128} PRT060318 inhibits convulxin-induced aggregation of human platelet-rich plasma (IC50 = 2.5 μM) in vitro and prevents thrombosis in a transgenic mouse model of heparin-induced thrombocytopenia. It induces chronic lymphocytic leukemia (CLL) B cell apoptosis and inhibits the secretion of chemokines CCL3, CCL4, and CXCL13.{39219} PRT060318 also inhibits CLL B cell chemotaxis and pseudoemperipolesis.  

     

    Brand:
    Cayman
    SKU:22476 -

    Out of stock

  • BMI1/RING1A and BMI1/RNF2 are E3 ubiquitin ligase complexes that mediate the monoubiquitination of histone 2A (H2A). This is an essential function of polycomb repressive complex 1 (PRC1).{30718} PRT4165 is an inhibitor of the ubiquitin ligase activity of PRC1.{30882,30883} It blocks BMI1/RING1A self-ubiquitination (IC50 = 3.9 µM), as well as polyubiquitination of topoisomerase 2α in cells.{30882} PRT4165 inhibits ubiquitination of H2A by either RNF2 or RING1. Through these actions, PRT4165 prevents the accumulation of detectable ubiquitin at DNA double-strand breaks, the retention of response proteins around breaks, and the repair of breaks.{30883}  

     

    Brand:
    Cayman
    SKU:-

    Available on backorder

  • BMI1/RING1A and BMI1/RNF2 are E3 ubiquitin ligase complexes that mediate the monoubiquitination of histone 2A (H2A). This is an essential function of polycomb repressive complex 1 (PRC1).{30718} PRT4165 is an inhibitor of the ubiquitin ligase activity of PRC1.{30882,30883} It blocks BMI1/RING1A self-ubiquitination (IC50 = 3.9 µM), as well as polyubiquitination of topoisomerase 2α in cells.{30882} PRT4165 inhibits ubiquitination of H2A by either RNF2 or RING1. Through these actions, PRT4165 prevents the accumulation of detectable ubiquitin at DNA double-strand breaks, the retention of response proteins around breaks, and the repair of breaks.{30883}  

     

    Brand:
    Cayman
    SKU:-

    Available on backorder

  • BMI1/RING1A and BMI1/RNF2 are E3 ubiquitin ligase complexes that mediate the monoubiquitination of histone 2A (H2A). This is an essential function of polycomb repressive complex 1 (PRC1).{30718} PRT4165 is an inhibitor of the ubiquitin ligase activity of PRC1.{30882,30883} It blocks BMI1/RING1A self-ubiquitination (IC50 = 3.9 µM), as well as polyubiquitination of topoisomerase 2α in cells.{30882} PRT4165 inhibits ubiquitination of H2A by either RNF2 or RING1. Through these actions, PRT4165 prevents the accumulation of detectable ubiquitin at DNA double-strand breaks, the retention of response proteins around breaks, and the repair of breaks.{30883}  

     

    Brand:
    Cayman
    SKU:-

    Available on backorder

  • Prucalopride is a potent and selective agonist of the serotonin (5-HT) receptor subtype 5-HT4 (Kis = 2.5 and 8 nM for human 5-HT4A and 5-HT4B, respectively).{38962} Prucalopride is greater than 250-fold selective for 5-HT4 over a panel of 53 overexpressed receptors, including 5-HT subtypes, but does bind to human dopamine D4 and sigma-1 (σ1) receptors and mouse 5-HT3 receptors (Kis = 2.3, 3.7, and 3.8 μM, respectively). It induces contractions in guinea pig colon with an EC50 value of 33 nM, an effect that is blocked by the 5-HT4 antagonist GR113808 but not the 5-HT2A and 5-HT3 antagonists ketanserin (Item No. 22058) and granisetron (Item No. 21239), respectively.{38963} It also facilitates non-cholinergic contractions induced by electrical stimulation. In fasted dogs, oral administration of prucalopride increases colonic motility by inhibiting distal colon contractions (ED50 = 0.04 mg/kg), an effect that is blocked by pretreatment with the 5-HT4 antagonist GR125487. Prucalopride (5-10 mg/kg, s.c.) increases acetylcholine and histamine levels in the rat prefrontal cortex by 2.4-fold and 3-fold, respectively, and increases the power of hippocampal theta oscillations.{38964} Formulations containing prucalopride have been used in the treatment of chronic idiopathic constipation.  

     

    Brand:
    Cayman
    SKU:24192 - 10 mg

    Available on backorder

  • Prucalopride is a potent and selective agonist of the serotonin (5-HT) receptor subtype 5-HT4 (Kis = 2.5 and 8 nM for human 5-HT4A and 5-HT4B, respectively).{38962} Prucalopride is greater than 250-fold selective for 5-HT4 over a panel of 53 overexpressed receptors, including 5-HT subtypes, but does bind to human dopamine D4 and sigma-1 (σ1) receptors and mouse 5-HT3 receptors (Kis = 2.3, 3.7, and 3.8 μM, respectively). It induces contractions in guinea pig colon with an EC50 value of 33 nM, an effect that is blocked by the 5-HT4 antagonist GR113808 but not the 5-HT2A and 5-HT3 antagonists ketanserin (Item No. 22058) and granisetron (Item No. 21239), respectively.{38963} It also facilitates non-cholinergic contractions induced by electrical stimulation. In fasted dogs, oral administration of prucalopride increases colonic motility by inhibiting distal colon contractions (ED50 = 0.04 mg/kg), an effect that is blocked by pretreatment with the 5-HT4 antagonist GR125487. Prucalopride (5-10 mg/kg, s.c.) increases acetylcholine and histamine levels in the rat prefrontal cortex by 2.4-fold and 3-fold, respectively, and increases the power of hippocampal theta oscillations.{38964} Formulations containing prucalopride have been used in the treatment of chronic idiopathic constipation.  

     

    Brand:
    Cayman
    SKU:24192 - 100 mg

    Available on backorder

  • Prucalopride is a potent and selective agonist of the serotonin (5-HT) receptor subtype 5-HT4 (Kis = 2.5 and 8 nM for human 5-HT4A and 5-HT4B, respectively).{38962} Prucalopride is greater than 250-fold selective for 5-HT4 over a panel of 53 overexpressed receptors, including 5-HT subtypes, but does bind to human dopamine D4 and sigma-1 (σ1) receptors and mouse 5-HT3 receptors (Kis = 2.3, 3.7, and 3.8 μM, respectively). It induces contractions in guinea pig colon with an EC50 value of 33 nM, an effect that is blocked by the 5-HT4 antagonist GR113808 but not the 5-HT2A and 5-HT3 antagonists ketanserin (Item No. 22058) and granisetron (Item No. 21239), respectively.{38963} It also facilitates non-cholinergic contractions induced by electrical stimulation. In fasted dogs, oral administration of prucalopride increases colonic motility by inhibiting distal colon contractions (ED50 = 0.04 mg/kg), an effect that is blocked by pretreatment with the 5-HT4 antagonist GR125487. Prucalopride (5-10 mg/kg, s.c.) increases acetylcholine and histamine levels in the rat prefrontal cortex by 2.4-fold and 3-fold, respectively, and increases the power of hippocampal theta oscillations.{38964} Formulations containing prucalopride have been used in the treatment of chronic idiopathic constipation.  

     

    Brand:
    Cayman
    SKU:24192 - 250 mg

    Available on backorder

  • Prucalopride is a potent and selective agonist of the serotonin (5-HT) receptor subtype 5-HT4 (Kis = 2.5 and 8 nM for human 5-HT4A and 5-HT4B, respectively).{38962} Prucalopride is greater than 250-fold selective for 5-HT4 over a panel of 53 overexpressed receptors, including 5-HT subtypes, but does bind to human dopamine D4 and sigma-1 (σ1) receptors and mouse 5-HT3 receptors (Kis = 2.3, 3.7, and 3.8 μM, respectively). It induces contractions in guinea pig colon with an EC50 value of 33 nM, an effect that is blocked by the 5-HT4 antagonist GR113808 but not the 5-HT2A and 5-HT3 antagonists ketanserin (Item No. 22058) and granisetron (Item No. 21239), respectively.{38963} It also facilitates non-cholinergic contractions induced by electrical stimulation. In fasted dogs, oral administration of prucalopride increases colonic motility by inhibiting distal colon contractions (ED50 = 0.04 mg/kg), an effect that is blocked by pretreatment with the 5-HT4 antagonist GR125487. Prucalopride (5-10 mg/kg, s.c.) increases acetylcholine and histamine levels in the rat prefrontal cortex by 2.4-fold and 3-fold, respectively, and increases the power of hippocampal theta oscillations.{38964} Formulations containing prucalopride have been used in the treatment of chronic idiopathic constipation.  

     

    Brand:
    Cayman
    SKU:24192 - 50 mg

    Available on backorder

  • Prulifloxacin is a prodrug form of the fluoroquinolone antibiotic ulifloxacin.{52851} In vivo, prulifloxacin increases survival in mouse models of systemic S. aureus, S. pyogenes, S. pneumoniae, E. coli, K. pneumoniae, S. marcescens, or P. aeruginosa infection (ED50s = 0.35-23 mg/kg). It also increases survival in a mouse model of K. pneumoniae-induced respiratory tract infection (ED50 = 0.981 mg/kg).  

     

    Brand:
    Cayman
    SKU:31624 - 1 g

    Available on backorder

  • Prulifloxacin is a prodrug form of the fluoroquinolone antibiotic ulifloxacin.{52851} In vivo, prulifloxacin increases survival in mouse models of systemic S. aureus, S. pyogenes, S. pneumoniae, E. coli, K. pneumoniae, S. marcescens, or P. aeruginosa infection (ED50s = 0.35-23 mg/kg). It also increases survival in a mouse model of K. pneumoniae-induced respiratory tract infection (ED50 = 0.981 mg/kg).  

     

    Brand:
    Cayman
    SKU:31624 - 250 mg

    Available on backorder

  • Prulifloxacin is a prodrug form of the fluoroquinolone antibiotic ulifloxacin.{52851} In vivo, prulifloxacin increases survival in mouse models of systemic S. aureus, S. pyogenes, S. pneumoniae, E. coli, K. pneumoniae, S. marcescens, or P. aeruginosa infection (ED50s = 0.35-23 mg/kg). It also increases survival in a mouse model of K. pneumoniae-induced respiratory tract infection (ED50 = 0.981 mg/kg).  

     

    Brand:
    Cayman
    SKU:31624 - 5 g

    Available on backorder

  • Prulifloxacin is a prodrug form of the fluoroquinolone antibiotic ulifloxacin.{52851} In vivo, prulifloxacin increases survival in mouse models of systemic S. aureus, S. pyogenes, S. pneumoniae, E. coli, K. pneumoniae, S. marcescens, or P. aeruginosa infection (ED50s = 0.35-23 mg/kg). It also increases survival in a mouse model of K. pneumoniae-induced respiratory tract infection (ED50 = 0.981 mg/kg).  

     

    Brand:
    Cayman
    SKU:31624 - 500 mg

    Available on backorder

  • Prunetin is an isoflavone that has been found in P. yedoensis and has diverse biological activities.{45706,16840,45707,45708,45709} It is an allosteric inhibitor of hamster liver aldehyde dehydrogenase 2 (ALDH2; IC50 = 0.45 µM) and an antagonist of the progesterone receptor when used at concentrations of 25 and 50 µM.{16840,45707} It has estrogenic activity in MVLN cells when used at concentrations ranging from 1 to 50 µM and inhibits proliferation of MCF-7 breast cancer cells when used at 0.01 to 50 µM.{45708} It decreases LPS-induced increases in nitric oxide (NO) and prostaglandin E2 (PGE2; Item No. 14010) levels, NOS2/iNOS expression, and NF-κB activation in RAW 264.7 macrophages when used at concentrations of 50 and 100 µM.{45706} Prunetin (10 mg/kg) prevents LPS-induced increases in serum TNF-α, IL-1β, and IL-6 levels in a mouse model of septic shock. It also inhibits the secretion of matrix metalloproteinase-3 (MMP-3) in isolated rabbit articular chondrocytes and prevents the production of MMP-3 in the knee joint of rats in a model of osteoarthritis following administration of a 50 or 100 µM dose into the knee joint.{45709}  

     

    Brand:
    Cayman
    SKU:29432 - 10 mg

    Available on backorder

  • Prunetin is an isoflavone that has been found in P. yedoensis and has diverse biological activities.{45706,16840,45707,45708,45709} It is an allosteric inhibitor of hamster liver aldehyde dehydrogenase 2 (ALDH2; IC50 = 0.45 µM) and an antagonist of the progesterone receptor when used at concentrations of 25 and 50 µM.{16840,45707} It has estrogenic activity in MVLN cells when used at concentrations ranging from 1 to 50 µM and inhibits proliferation of MCF-7 breast cancer cells when used at 0.01 to 50 µM.{45708} It decreases LPS-induced increases in nitric oxide (NO) and prostaglandin E2 (PGE2; Item No. 14010) levels, NOS2/iNOS expression, and NF-κB activation in RAW 264.7 macrophages when used at concentrations of 50 and 100 µM.{45706} Prunetin (10 mg/kg) prevents LPS-induced increases in serum TNF-α, IL-1β, and IL-6 levels in a mouse model of septic shock. It also inhibits the secretion of matrix metalloproteinase-3 (MMP-3) in isolated rabbit articular chondrocytes and prevents the production of MMP-3 in the knee joint of rats in a model of osteoarthritis following administration of a 50 or 100 µM dose into the knee joint.{45709}  

     

    Brand:
    Cayman
    SKU:29432 - 25 mg

    Available on backorder

  • Prunetin is an isoflavone that has been found in P. yedoensis and has diverse biological activities.{45706,16840,45707,45708,45709} It is an allosteric inhibitor of hamster liver aldehyde dehydrogenase 2 (ALDH2; IC50 = 0.45 µM) and an antagonist of the progesterone receptor when used at concentrations of 25 and 50 µM.{16840,45707} It has estrogenic activity in MVLN cells when used at concentrations ranging from 1 to 50 µM and inhibits proliferation of MCF-7 breast cancer cells when used at 0.01 to 50 µM.{45708} It decreases LPS-induced increases in nitric oxide (NO) and prostaglandin E2 (PGE2; Item No. 14010) levels, NOS2/iNOS expression, and NF-κB activation in RAW 264.7 macrophages when used at concentrations of 50 and 100 µM.{45706} Prunetin (10 mg/kg) prevents LPS-induced increases in serum TNF-α, IL-1β, and IL-6 levels in a mouse model of septic shock. It also inhibits the secretion of matrix metalloproteinase-3 (MMP-3) in isolated rabbit articular chondrocytes and prevents the production of MMP-3 in the knee joint of rats in a model of osteoarthritis following administration of a 50 or 100 µM dose into the knee joint.{45709}  

     

    Brand:
    Cayman
    SKU:29432 - 5 mg

    Available on backorder

  • PRX-08066 is an antagonist of the serotonin (5-HT) receptor subtype 5-HT2B.{52798} It binds to 5-HT2B receptors (Ki = 3.4 nM) and inhibits 5-HT-induced MAPK activation and thymidine incorporation in CHO cells expressing human 5-HT2B (IC50s = ~12 and ~3 nM, respectively). PRX-08066 (50 and 100 mg/kg) reduces peak pulmonary arterial pressure and right ventricular hypertrophy in a rat model of pulmonary hypertension induced by monocrotaline (MCT; Item No. 16666).  

     

    Brand:
    Cayman
    SKU:31477 - 1 mg

    Available on backorder

  • PRX-08066 is an antagonist of the serotonin (5-HT) receptor subtype 5-HT2B.{52798} It binds to 5-HT2B receptors (Ki = 3.4 nM) and inhibits 5-HT-induced MAPK activation and thymidine incorporation in CHO cells expressing human 5-HT2B (IC50s = ~12 and ~3 nM, respectively). PRX-08066 (50 and 100 mg/kg) reduces peak pulmonary arterial pressure and right ventricular hypertrophy in a rat model of pulmonary hypertension induced by monocrotaline (MCT; Item No. 16666).  

     

    Brand:
    Cayman
    SKU:31477 - 10 mg

    Available on backorder

  • PRX-08066 is an antagonist of the serotonin (5-HT) receptor subtype 5-HT2B.{52798} It binds to 5-HT2B receptors (Ki = 3.4 nM) and inhibits 5-HT-induced MAPK activation and thymidine incorporation in CHO cells expressing human 5-HT2B (IC50s = ~12 and ~3 nM, respectively). PRX-08066 (50 and 100 mg/kg) reduces peak pulmonary arterial pressure and right ventricular hypertrophy in a rat model of pulmonary hypertension induced by monocrotaline (MCT; Item No. 16666).  

     

    Brand:
    Cayman
    SKU:31477 - 5 mg

    Available on backorder

  • Nuclear factor-κB (NF-κB) is a protein complex which modulates gene transcription relevant to cellular responses to inflammation, stress, infection, and other factors.{19815} The inhibitor of NF-κB kinase β (IKKβ), in complex with IKKα and IKKγ, phosphorylates inhibitor of NF-κB A and B (IκA and IκB) and other proteins involved in NF-κB signaling, and thus plays a central regulatory role.{19815} PS-1145 is a potent inhibitor of IKKβ (IC50 = 88-100 nM).{23652,23654} Through this action, it is used to elucidate roles for NF-κB both in cells and in vivo.{23652,23651,23653,23650}  

     

    Brand:
    Cayman
    SKU:-
  • Nuclear factor-κB (NF-κB) is a protein complex which modulates gene transcription relevant to cellular responses to inflammation, stress, infection, and other factors.{19815} The inhibitor of NF-κB kinase β (IKKβ), in complex with IKKα and IKKγ, phosphorylates inhibitor of NF-κB A and B (IκA and IκB) and other proteins involved in NF-κB signaling, and thus plays a central regulatory role.{19815} PS-1145 is a potent inhibitor of IKKβ (IC50 = 88-100 nM).{23652,23654} Through this action, it is used to elucidate roles for NF-κB both in cells and in vivo.{23652,23651,23653,23650}  

     

    Brand:
    Cayman
    SKU:-
  • Nuclear factor-κB (NF-κB) is a protein complex which modulates gene transcription relevant to cellular responses to inflammation, stress, infection, and other factors.{19815} The inhibitor of NF-κB kinase β (IKKβ), in complex with IKKα and IKKγ, phosphorylates inhibitor of NF-κB A and B (IκA and IκB) and other proteins involved in NF-κB signaling, and thus plays a central regulatory role.{19815} PS-1145 is a potent inhibitor of IKKβ (IC50 = 88-100 nM).{23652,23654} Through this action, it is used to elucidate roles for NF-κB both in cells and in vivo.{23652,23651,23653,23650}  

     

    Brand:
    Cayman
    SKU:-
  • PS-210 is an activator of phosphoinositide-dependent protein kinase 1 (PDK1) that increases its thermal stability.{54305,54306} It is selective for PDK-1 over a panel of 120 kinases at 10 µM.{54305} PS-210 (2 µM) increases the activity of wild-type PDK1 but not PDK1 with a mutation in the PIF-binding pocket.  

     

    Brand:
    Cayman
    SKU:30923 - 1 mg

    Available on backorder

  • PS-210 is an activator of phosphoinositide-dependent protein kinase 1 (PDK1) that increases its thermal stability.{54305,54306} It is selective for PDK-1 over a panel of 120 kinases at 10 µM.{54305} PS-210 (2 µM) increases the activity of wild-type PDK1 but not PDK1 with a mutation in the PIF-binding pocket.  

     

    Brand:
    Cayman
    SKU:30923 - 10 mg

    Available on backorder

  • PS-210 is an activator of phosphoinositide-dependent protein kinase 1 (PDK1) that increases its thermal stability.{54305,54306} It is selective for PDK-1 over a panel of 120 kinases at 10 µM.{54305} PS-210 (2 µM) increases the activity of wild-type PDK1 but not PDK1 with a mutation in the PIF-binding pocket.  

     

    Brand:
    Cayman
    SKU:30923 - 5 mg

    Available on backorder

  • PSB-1115 is an antagonist of the adenosine A2B receptor (Ki = 53.4 nM).{40515} It is selective for A2B over A1 and A2A receptors, which have Ki values of 2,200 and 24,000 nM, respectively, and over the A3 receptor, which it inhibits only 14% at a concentration of 10 µM. PSB-1115 pre-treatment reduces relaxation of rat trachea induced by repeated dosing of the non-selective adenosine agonist NECA (Item No. 21420).{40516}  

     

    Brand:
    Cayman
    SKU:23929 - 10 mg

    Available on backorder

  • PSB-1115 is an antagonist of the adenosine A2B receptor (Ki = 53.4 nM).{40515} It is selective for A2B over A1 and A2A receptors, which have Ki values of 2,200 and 24,000 nM, respectively, and over the A3 receptor, which it inhibits only 14% at a concentration of 10 µM. PSB-1115 pre-treatment reduces relaxation of rat trachea induced by repeated dosing of the non-selective adenosine agonist NECA (Item No. 21420).{40516}  

     

    Brand:
    Cayman
    SKU:23929 - 25 mg

    Available on backorder

  • PSB-1115 is an antagonist of the adenosine A2B receptor (Ki = 53.4 nM).{40515} It is selective for A2B over A1 and A2A receptors, which have Ki values of 2,200 and 24,000 nM, respectively, and over the A3 receptor, which it inhibits only 14% at a concentration of 10 µM. PSB-1115 pre-treatment reduces relaxation of rat trachea induced by repeated dosing of the non-selective adenosine agonist NECA (Item No. 21420).{40516}  

     

    Brand:
    Cayman
    SKU:23929 - 5 mg

    Available on backorder

  • PSB-12379 is an inhibitor of ecto-5’-nucleotidase (CD73; Kis = 2.21 and 9.03 nM for the recombinant human and rat enzyme, respectively).{50087} It is selective for CD73 over human nucleoside triphosphate diphosphohydrolase 1 (NTPDase 1), -2, and -3, ectonucleotide pyrophosphatase/phosphodiesterase family member 1 (ENPP1), -2, and -3 (Kis = >10,000 nM for all), as well as the purinergic P2Y1 and P2Y12 receptors at 10 µM. PSB-12379 inhibits CD73 in isolated human serum with a Ki value of 18.8 nM.  

     

    Brand:
    Cayman
    SKU:28446 - 1 mg

    Available on backorder

  • PSB-12379 is an inhibitor of ecto-5’-nucleotidase (CD73; Kis = 2.21 and 9.03 nM for the recombinant human and rat enzyme, respectively).{50087} It is selective for CD73 over human nucleoside triphosphate diphosphohydrolase 1 (NTPDase 1), -2, and -3, ectonucleotide pyrophosphatase/phosphodiesterase family member 1 (ENPP1), -2, and -3 (Kis = >10,000 nM for all), as well as the purinergic P2Y1 and P2Y12 receptors at 10 µM. PSB-12379 inhibits CD73 in isolated human serum with a Ki value of 18.8 nM.  

     

    Brand:
    Cayman
    SKU:28446 - 10 mg

    Available on backorder

  • PSB-12379 is an inhibitor of ecto-5’-nucleotidase (CD73; Kis = 2.21 and 9.03 nM for the recombinant human and rat enzyme, respectively).{50087} It is selective for CD73 over human nucleoside triphosphate diphosphohydrolase 1 (NTPDase 1), -2, and -3, ectonucleotide pyrophosphatase/phosphodiesterase family member 1 (ENPP1), -2, and -3 (Kis = >10,000 nM for all), as well as the purinergic P2Y1 and P2Y12 receptors at 10 µM. PSB-12379 inhibits CD73 in isolated human serum with a Ki value of 18.8 nM.  

     

    Brand:
    Cayman
    SKU:28446 - 5 mg

    Available on backorder

  • PSB-603 is an antagonist of the adenosine A2B receptor (Ki = 0.553 nM).{42518} It is selective for adenosine A2B over A1, A2A, and A3 receptors (Kis = >10,000 nM). It reduces intracellular calcium concentrations in Jurkat T cells expressing the human A2B receptor (IC50 = 1.13 nM). PSB-603 reduces Zika viral plaque formation (IC50 = 43.8 nM) without affecting cell viability of A549 cells when used at concentrations up to 1 µM.{42519} In vivo, PSB-603 (0.25 µg/head, i.p.) delays tumor growth and reduces tumor volume and the number of pulmonary metastases in the B16 mouse model of melanoma via inhibition of induction of regulatory T cells.{42520}  

     

    Brand:
    Cayman
    SKU:25637 - 1 mg

    Available on backorder

  • PSB-603 is an antagonist of the adenosine A2B receptor (Ki = 0.553 nM).{42518} It is selective for adenosine A2B over A1, A2A, and A3 receptors (Kis = >10,000 nM). It reduces intracellular calcium concentrations in Jurkat T cells expressing the human A2B receptor (IC50 = 1.13 nM). PSB-603 reduces Zika viral plaque formation (IC50 = 43.8 nM) without affecting cell viability of A549 cells when used at concentrations up to 1 µM.{42519} In vivo, PSB-603 (0.25 µg/head, i.p.) delays tumor growth and reduces tumor volume and the number of pulmonary metastases in the B16 mouse model of melanoma via inhibition of induction of regulatory T cells.{42520}  

     

    Brand:
    Cayman
    SKU:25637 - 10 mg

    Available on backorder

  • PSB-603 is an antagonist of the adenosine A2B receptor (Ki = 0.553 nM).{42518} It is selective for adenosine A2B over A1, A2A, and A3 receptors (Kis = >10,000 nM). It reduces intracellular calcium concentrations in Jurkat T cells expressing the human A2B receptor (IC50 = 1.13 nM). PSB-603 reduces Zika viral plaque formation (IC50 = 43.8 nM) without affecting cell viability of A549 cells when used at concentrations up to 1 µM.{42519} In vivo, PSB-603 (0.25 µg/head, i.p.) delays tumor growth and reduces tumor volume and the number of pulmonary metastases in the B16 mouse model of melanoma via inhibition of induction of regulatory T cells.{42520}  

     

    Brand:
    Cayman
    SKU:25637 - 25 mg

    Available on backorder

  • PSB-603 is an antagonist of the adenosine A2B receptor (Ki = 0.553 nM).{42518} It is selective for adenosine A2B over A1, A2A, and A3 receptors (Kis = >10,000 nM). It reduces intracellular calcium concentrations in Jurkat T cells expressing the human A2B receptor (IC50 = 1.13 nM). PSB-603 reduces Zika viral plaque formation (IC50 = 43.8 nM) without affecting cell viability of A549 cells when used at concentrations up to 1 µM.{42519} In vivo, PSB-603 (0.25 µg/head, i.p.) delays tumor growth and reduces tumor volume and the number of pulmonary metastases in the B16 mouse model of melanoma via inhibition of induction of regulatory T cells.{42520}  

     

    Brand:
    Cayman
    SKU:25637 - 5 mg

    Available on backorder

  • PSB-KD107 is an agonist of the orphan G protein-coupled receptor GPR18 (EC50 = 0.56 µM in a β-arrestin recruitment assay using CHO cells expressing the human receptor).{58090,44024} It is selective for GPR18 over GPR55, as well as cannabinoid (CB) receptor 1 (CB1) and CB2, at 10 µM but also binds to the adenosine A2A receptor (Ki = 0.33 µM for the rat receptor).{58090,58091}  

     

    Brand:
    Cayman
    SKU:31393 - 1 mg

    Available on backorder

  • PSB-KD107 is an agonist of the orphan G protein-coupled receptor GPR18 (EC50 = 0.56 µM in a β-arrestin recruitment assay using CHO cells expressing the human receptor).{58090,44024} It is selective for GPR18 over GPR55, as well as cannabinoid (CB) receptor 1 (CB1) and CB2, at 10 µM but also binds to the adenosine A2A receptor (Ki = 0.33 µM for the rat receptor).{58090,58091}  

     

    Brand:
    Cayman
    SKU:31393 - 10 mg

    Available on backorder

  • PSB-KD107 is an agonist of the orphan G protein-coupled receptor GPR18 (EC50 = 0.56 µM in a β-arrestin recruitment assay using CHO cells expressing the human receptor).{58090,44024} It is selective for GPR18 over GPR55, as well as cannabinoid (CB) receptor 1 (CB1) and CB2, at 10 µM but also binds to the adenosine A2A receptor (Ki = 0.33 µM for the rat receptor).{58090,58091}  

     

    Brand:
    Cayman
    SKU:31393 - 25 mg

    Available on backorder

  • PSB-KD107 is an agonist of the orphan G protein-coupled receptor GPR18 (EC50 = 0.56 µM in a β-arrestin recruitment assay using CHO cells expressing the human receptor).{58090,44024} It is selective for GPR18 over GPR55, as well as cannabinoid (CB) receptor 1 (CB1) and CB2, at 10 µM but also binds to the adenosine A2A receptor (Ki = 0.33 µM for the rat receptor).{58090,58091}  

     

    Brand:
    Cayman
    SKU:31393 - 5 mg

    Available on backorder

  • PSB-SB1202 is a benzylcoumarin compound that acts as an agonist at the major cannabinoid (CB) receptors, with EC50 values of 56 and 14 nM at CB1 and CB2, respectively.{26899} It is highly selective for the CB1 and CB2 receptors (Kis = 32 and 49 nM, respectively), having minimal activity at GPR55 (IC50 = 6.4 µM), a receptor that binds CBs and lysophosphatidylinositol.{26900}  

     

    Brand:
    Cayman
    SKU:-
  • PSB-SB1202 is a benzylcoumarin compound that acts as an agonist at the major cannabinoid (CB) receptors, with EC50 values of 56 and 14 nM at CB1 and CB2, respectively.{26899} It is highly selective for the CB1 and CB2 receptors (Kis = 32 and 49 nM, respectively), having minimal activity at GPR55 (IC50 = 6.4 µM), a receptor that binds CBs and lysophosphatidylinositol.{26900}  

     

    Brand:
    Cayman
    SKU:-
  • PSB-SB1202 is a benzylcoumarin compound that acts as an agonist at the major cannabinoid (CB) receptors, with EC50 values of 56 and 14 nM at CB1 and CB2, respectively.{26899} It is highly selective for the CB1 and CB2 receptors (Kis = 32 and 49 nM, respectively), having minimal activity at GPR55 (IC50 = 6.4 µM), a receptor that binds CBs and lysophosphatidylinositol.{26900}  

     

    Brand:
    Cayman
    SKU:-
  • PSC 833 is a non-immunosuppressant derivative of cyclosporine and potent multidrug-resistance (MDR) modulator.{43099} It restores sensitivity of MDR-P388 murine leukemia cells to cytostatic agents when used at concentrations of 70, 33, 45, 34, and 26 nM in combination with colchicine, vincristine (Item No. 11764), daunorubicin (Item No. 14159), doxorubicin (Item No. 15007), and etoposide (Item No. 12092), respectively. PSC 833 inhibits basal-to-apical transport and increases apical-to-basal transport of [14C]docetaxel in LLC-GA5-COLO150 cells that overexpress human P-glycoprotein (P-gp).{43100} In vivo, PSC 833 increases survival time in MDR-P388 tumor-bearing mice and in an MDR-L1210 leukemia mouse xenograft model when administered in combination with doxorubicin.{43099,43101} PSC 833 also prolongs the anti-hyperalgesic effects of intraperitoneally administered pregabalin in a mouse model of cold stress-induced central pain.{43102}  

     

    Brand:
    Cayman
    SKU:20391 -

    Available on backorder

  • PSC 833 is a non-immunosuppressant derivative of cyclosporine and potent multidrug-resistance (MDR) modulator.{43099} It restores sensitivity of MDR-P388 murine leukemia cells to cytostatic agents when used at concentrations of 70, 33, 45, 34, and 26 nM in combination with colchicine, vincristine (Item No. 11764), daunorubicin (Item No. 14159), doxorubicin (Item No. 15007), and etoposide (Item No. 12092), respectively. PSC 833 inhibits basal-to-apical transport and increases apical-to-basal transport of [14C]docetaxel in LLC-GA5-COLO150 cells that overexpress human P-glycoprotein (P-gp).{43100} In vivo, PSC 833 increases survival time in MDR-P388 tumor-bearing mice and in an MDR-L1210 leukemia mouse xenograft model when administered in combination with doxorubicin.{43099,43101} PSC 833 also prolongs the anti-hyperalgesic effects of intraperitoneally administered pregabalin in a mouse model of cold stress-induced central pain.{43102}  

     

    Brand:
    Cayman
    SKU:20391 -

    Available on backorder

  • Pseudoerythromycin A enol ether is a degradation product of erythromycin. It does not possess antibiotic activity and can be used as an analytical standard for erythromycin A stability studies.{25101}  

     

    Brand:
    Cayman
    SKU:-
  • Pseudoerythromycin A enol ether is a degradation product of erythromycin. It does not possess antibiotic activity and can be used as an analytical standard for erythromycin A stability studies.{25101}  

     

    Brand:
    Cayman
    SKU:-
  • Pseudoginsenoside F11 is an ocotillol-type ginsenoside that has been found in P. ginseng and has diverse biological activities.{54075,54076,54077,54078} In vivo, pseudoginsenoside F11 (10 mg/kg) prevents tubular cell apoptosis, decreases in renal glutathione peroxidase (GPX) and superoxide dismutase (SOD) levels, and increases in renal lipid peroxide levels in a rat model of nephrotoxicity induced by cisplatin (Item No. 13119).{54075} It reduces infarct size, brain water content, and cortical accumulation of autophagosomes in a rat model of ischemic stroke induced by permanent middle cerebral artery occlusion.{54076} Pseudoginsenoside F11 (4 and 8 mg/kg) inhibits morphine-induced memory impairment in the Morris water maze and development of morphine-induced conditioned place preference in mice.{54077} It also reduces hippocampal advanced glycation end product (AGE) and malondialdehyde (MDA) levels, increases hippocampal SOD activity and glutathione (GSH) levels, and attenuates cognitive impairment in the Morris water maze in a mouse model of D-galactose-induced mild cognitive impairment.{54078}  

     

    Brand:
    Cayman
    SKU:30222 - 100 mg

    Available on backorder

  • Pseudoginsenoside F11 is an ocotillol-type ginsenoside that has been found in P. ginseng and has diverse biological activities.{54075,54076,54077,54078} In vivo, pseudoginsenoside F11 (10 mg/kg) prevents tubular cell apoptosis, decreases in renal glutathione peroxidase (GPX) and superoxide dismutase (SOD) levels, and increases in renal lipid peroxide levels in a rat model of nephrotoxicity induced by cisplatin (Item No. 13119).{54075} It reduces infarct size, brain water content, and cortical accumulation of autophagosomes in a rat model of ischemic stroke induced by permanent middle cerebral artery occlusion.{54076} Pseudoginsenoside F11 (4 and 8 mg/kg) inhibits morphine-induced memory impairment in the Morris water maze and development of morphine-induced conditioned place preference in mice.{54077} It also reduces hippocampal advanced glycation end product (AGE) and malondialdehyde (MDA) levels, increases hippocampal SOD activity and glutathione (GSH) levels, and attenuates cognitive impairment in the Morris water maze in a mouse model of D-galactose-induced mild cognitive impairment.{54078}  

     

    Brand:
    Cayman
    SKU:30222 - 25 mg

    Available on backorder

  • Pseudoginsenoside F11 is an ocotillol-type ginsenoside that has been found in P. ginseng and has diverse biological activities.{54075,54076,54077,54078} In vivo, pseudoginsenoside F11 (10 mg/kg) prevents tubular cell apoptosis, decreases in renal glutathione peroxidase (GPX) and superoxide dismutase (SOD) levels, and increases in renal lipid peroxide levels in a rat model of nephrotoxicity induced by cisplatin (Item No. 13119).{54075} It reduces infarct size, brain water content, and cortical accumulation of autophagosomes in a rat model of ischemic stroke induced by permanent middle cerebral artery occlusion.{54076} Pseudoginsenoside F11 (4 and 8 mg/kg) inhibits morphine-induced memory impairment in the Morris water maze and development of morphine-induced conditioned place preference in mice.{54077} It also reduces hippocampal advanced glycation end product (AGE) and malondialdehyde (MDA) levels, increases hippocampal SOD activity and glutathione (GSH) levels, and attenuates cognitive impairment in the Morris water maze in a mouse model of D-galactose-induced mild cognitive impairment.{54078}  

     

    Brand:
    Cayman
    SKU:30222 - 250 mg

    Available on backorder

  • Pseudoginsenoside F11 is an ocotillol-type ginsenoside that has been found in P. ginseng and has diverse biological activities.{54075,54076,54077,54078} In vivo, pseudoginsenoside F11 (10 mg/kg) prevents tubular cell apoptosis, decreases in renal glutathione peroxidase (GPX) and superoxide dismutase (SOD) levels, and increases in renal lipid peroxide levels in a rat model of nephrotoxicity induced by cisplatin (Item No. 13119).{54075} It reduces infarct size, brain water content, and cortical accumulation of autophagosomes in a rat model of ischemic stroke induced by permanent middle cerebral artery occlusion.{54076} Pseudoginsenoside F11 (4 and 8 mg/kg) inhibits morphine-induced memory impairment in the Morris water maze and development of morphine-induced conditioned place preference in mice.{54077} It also reduces hippocampal advanced glycation end product (AGE) and malondialdehyde (MDA) levels, increases hippocampal SOD activity and glutathione (GSH) levels, and attenuates cognitive impairment in the Morris water maze in a mouse model of D-galactose-induced mild cognitive impairment.{54078}  

     

    Brand:
    Cayman
    SKU:30222 - 50 mg

    Available on backorder

  • Pseudolaric acid B (PAB) is a diterpene acid isolated from the bark of P. kaempferi, a traditional Chinese medicinal plant. It has reported antifungal activities, consistent with its traditional use in the treatment of dermatological fungal infections.{17624} Moreover, PAB has diverse effects that are relevant to cancer therapy, including inducing apoptosis of cancer cells (IC50 = ~1 μM), preventing angiogenesis, and inhibiting tumor growth in vivo.{17625,17627,17626}  

     

    Brand:
    Cayman
    SKU:-
  • Pseudolaric acid B (PAB) is a diterpene acid isolated from the bark of P. kaempferi, a traditional Chinese medicinal plant. It has reported antifungal activities, consistent with its traditional use in the treatment of dermatological fungal infections.{17624} Moreover, PAB has diverse effects that are relevant to cancer therapy, including inducing apoptosis of cancer cells (IC50 = ~1 μM), preventing angiogenesis, and inhibiting tumor growth in vivo.{17625,17627,17626}  

     

    Brand:
    Cayman
    SKU:-
  • Pseudolaric acid B (PAB) is a diterpene acid isolated from the bark of P. kaempferi, a traditional Chinese medicinal plant. It has reported antifungal activities, consistent with its traditional use in the treatment of dermatological fungal infections.{17624} Moreover, PAB has diverse effects that are relevant to cancer therapy, including inducing apoptosis of cancer cells (IC50 = ~1 μM), preventing angiogenesis, and inhibiting tumor growth in vivo.{17625,17627,17626}  

     

    Brand:
    Cayman
    SKU:-
  • Pseudolaric acid B (PAB) is a diterpene acid isolated from the bark of P. kaempferi, a traditional Chinese medicinal plant. It has reported antifungal activities, consistent with its traditional use in the treatment of dermatological fungal infections.{17624} Moreover, PAB has diverse effects that are relevant to cancer therapy, including inducing apoptosis of cancer cells (IC50 = ~1 μM), preventing angiogenesis, and inhibiting tumor growth in vivo.{17625,17627,17626}  

     

    Brand:
    Cayman
    SKU:-
  • Pseudomonic acid is an antibiotic that acts by inhibiting isoleucyl-tRNA synthetase in bacterial cell walls, slowing the growth of bacteria with an MIC value of 0.05 µg/ml in S. aureus.{37158},{37159},{37160} It is mainly active against Gram-positive bacteria.{37161}  

     

    Brand:
    Cayman
    SKU:23238 - 10 mg

    Available on backorder

  • Pseudomonic acid is an antibiotic that acts by inhibiting isoleucyl-tRNA synthetase in bacterial cell walls, slowing the growth of bacteria with an MIC value of 0.05 µg/ml in S. aureus.{37158},{37159},{37160} It is mainly active against Gram-positive bacteria.{37161}  

     

    Brand:
    Cayman
    SKU:23238 - 100 mg

    Available on backorder

  • Pseudomonic acid is an antibiotic that acts by inhibiting isoleucyl-tRNA synthetase in bacterial cell walls, slowing the growth of bacteria with an MIC value of 0.05 µg/ml in S. aureus.{37158},{37159},{37160} It is mainly active against Gram-positive bacteria.{37161}  

     

    Brand:
    Cayman
    SKU:23238 - 25 mg

    Available on backorder

  • Pseudomonic acid is an antibiotic that acts by inhibiting isoleucyl-tRNA synthetase in bacterial cell walls, slowing the growth of bacteria with an MIC value of 0.05 µg/ml in S. aureus.{37158},{37159},{37160} It is mainly active against Gram-positive bacteria.{37161}  

     

    Brand:
    Cayman
    SKU:23238 - 50 mg

    Available on backorder

  • Pseurotin A is a secondary metabolite produced by Aspergillus and other fungi.{22508} Its expression is induced in response to hypoxia.{22509} Pseurotin A has been shown to inhibit IgE production by mouse B cells in culture (IC50 = 3.6 μM) and dose-dependently (0.4-25 μg/ml) stimulate neuritogenic activity in rat pheochromocytoma PC12 cells.{22505,22507} It also demonstrates nematicidal activity at 300 μg/ml.{22504}  

     

    Brand:
    Cayman
    SKU:-
  • Pseurotin A is a secondary metabolite produced by Aspergillus and other fungi.{22508} Its expression is induced in response to hypoxia.{22509} Pseurotin A has been shown to inhibit IgE production by mouse B cells in culture (IC50 = 3.6 μM) and dose-dependently (0.4-25 μg/ml) stimulate neuritogenic activity in rat pheochromocytoma PC12 cells.{22505,22507} It also demonstrates nematicidal activity at 300 μg/ml.{22504}  

     

    Brand:
    Cayman
    SKU:-
  • PSI-6130 is a nucleoside inhibitor of the NS5B RNA polymerase of hepatitis C virus (HCV; Ki = 4.3 µM).{48516} It inhibits HCV genotype 1b (GT-1b) Con1 and GT-1a H77 viral replication in Huh7 replicon cells using a luciferase-based assay (EC50s = 0.51 and 0.30 µM, respectively). PSI-6130 also inhibits replication of HCV GT-1b and GT-1a replicons from clinical isolates, with EC50 values ranging from 0.60 to 1.41 µM, and 0.20 to 0.43 µM, respectively, in the same assay. It has little or no activity against West Nile Virus (WNV), Dengue type 2 virus (DV), human immunodeficiency virus (HIV), or hepatitis B virus (HBV; EC90s = 46.3, >100, >100, and >10 µM, respectively).{48517}  

     

    Brand:
    Cayman
    SKU:-
  • PSI-6130 is a nucleoside inhibitor of the NS5B RNA polymerase of hepatitis C virus (HCV; Ki = 4.3 µM).{48516} It inhibits HCV genotype 1b (GT-1b) Con1 and GT-1a H77 viral replication in Huh7 replicon cells using a luciferase-based assay (EC50s = 0.51 and 0.30 µM, respectively). PSI-6130 also inhibits replication of HCV GT-1b and GT-1a replicons from clinical isolates, with EC50 values ranging from 0.60 to 1.41 µM, and 0.20 to 0.43 µM, respectively, in the same assay. It has little or no activity against West Nile Virus (WNV), Dengue type 2 virus (DV), human immunodeficiency virus (HIV), or hepatitis B virus (HBV; EC90s = 46.3, >100, >100, and >10 µM, respectively).{48517}  

     

    Brand:
    Cayman
    SKU:-
  • PSI-6206 is the deaminated derivative of PSI-6130, a selective inhibitor of hepatitis C virus (HCV) replication that targets the NS5B polymerase.{30617,30616} PSI-6206, itself, does not inhibit HCV replication in the HCV subgenomic replicon assay.{30617,30616} However, its triphosphate form, RO 2433-TP, does inhibit RNA synthesis by HCV polymerase (IC50 = 1.19 µM for inhibition of RNA synthesis activity of HCV replicase).{30617,30616}  

     

    Brand:
    Cayman
    SKU:-

    Available on backorder

  • PSI-6206 is the deaminated derivative of PSI-6130, a selective inhibitor of hepatitis C virus (HCV) replication that targets the NS5B polymerase.{30617,30616} PSI-6206, itself, does not inhibit HCV replication in the HCV subgenomic replicon assay.{30617,30616} However, its triphosphate form, RO 2433-TP, does inhibit RNA synthesis by HCV polymerase (IC50 = 1.19 µM for inhibition of RNA synthesis activity of HCV replicase).{30617,30616}  

     

    Brand:
    Cayman
    SKU:-

    Available on backorder

  • PSI-7977 is a phosphoramidate prodrug of PSI-7851, a nucleoside analog that, when phosphorylated, inhibits the RNA-dependent RNA polymerase of hepatitis C virus (EC50 = 92 nM).{25066,25069,25067} PSI-7977 is effective in vitro and in vivo.{25069,25065,25068}  

     

    Brand:
    Cayman
    SKU:-
  • PSI-7977 is a phosphoramidate prodrug of PSI-7851, a nucleoside analog that, when phosphorylated, inhibits the RNA-dependent RNA polymerase of hepatitis C virus (EC50 = 92 nM).{25066,25069,25067} PSI-7977 is effective in vitro and in vivo.{25069,25065,25068}  

     

    Brand:
    Cayman
    SKU:-
  • PSI-7977 is a phosphoramidate prodrug of PSI-7851, a nucleoside analog that, when phosphorylated, inhibits the RNA-dependent RNA polymerase of hepatitis C virus (EC50 = 92 nM).{25066,25069,25067} PSI-7977 is effective in vitro and in vivo.{25069,25065,25068}  

     

    Brand:
    Cayman
    SKU:-
  • PSI-7977-13C-d3 is intended for use as an internal standard for the quantification of PSI-7977 (Item No. 15402) by GC- or LC-MS. PSI-7977 is a phosphoramidate prodrug of PSI-7851, a nucleoside analog that, when phosphorylated, inhibits the RNA-dependent RNA polymerase of hepatitis C virus (EC50 = 92 nM).{25066,25069,25067} PSI-7977 is effective in vitro and in vivo.{25069,25065,25068}  

     

    Brand:
    Cayman
    SKU:25045 - 1 mg

    Available on backorder

  • Psicofuranine is an antibiotic and antitumor compound that acts as an inhibitor of xanthosine monophosphate (XMP) aminase (IC50 = 67 µM), causing guanine deficiency in enteric bacteria.{31232,31233,31231}  

     

    Brand:
    Cayman
    SKU:19574 -

    Available on backorder

  • Psicofuranine is an antibiotic and antitumor compound that acts as an inhibitor of xanthosine monophosphate (XMP) aminase (IC50 = 67 µM), causing guanine deficiency in enteric bacteria.{31232,31233,31231}  

     

    Brand:
    Cayman
    SKU:19574 -

    Available on backorder

  • Psilocybin (exempt preparation) (Item No. 15695) is an analytical reference standard categorized as a tryptamine. It is a prodrug that is rapidly metabolized to psilocin (4-hydroxy DMT; Item No. 11864), which acts as an agonist at the 5-hydroxy tryptamine (5-HT) receptors 5-HT1A (Ki = 49 nM) and 5-HT2A, 5-HT2B, and 5-HT2C (EC50s = 24, 58, and 30 nM, respectively).{26036,22700,25255} Psilocybin is regulated as a Schedule I compound in the United States. Psilocybin (Item No. 15695) is provided as a DEA exempt preparation. This product is intended for research and forensic applications.  

     

    Brand:
    Cayman
    SKU:-
  • GPR119 (previously designated SNORF25) is an orphan G protein-coupled receptor expressed predominantly in the pancreas and gastrointestinal tract in humans and in the brain, pancreas, and gastrointestinal tract in rodents. It mediates a reduction in food intake and body weight gain in rats upon treatment with oleoyl ethanolamide (OEA), an endogenous, potent agonist for PPARα.{11423,14046} PSN375963 is a potent and selective agonist of GPR119 that shows similar potency to oleoyl ethanolamide (OEA) at both recombinant mouse and human GPR119 receptors, exhibiting EC50 values of 8.4 and 7.9 µM, respectively (EC50 values for OEA are 3.2 and 2.9 µM, respectively).{14046} These data suggest that PSN375963 may be useful as a therapeutic agent for the treatment of obesity.  

     

    Brand:
    Cayman
    SKU:10008593 - 1 mg

    Available on backorder

  • GPR119 (previously designated SNORF25) is an orphan G protein-coupled receptor expressed predominantly in the pancreas and gastrointestinal tract in humans and in the brain, pancreas, and gastrointestinal tract in rodents. It mediates a reduction in food intake and body weight gain in rats upon treatment with oleoyl ethanolamide (OEA), an endogenous, potent agonist for PPARα.{11423,14046} PSN375963 is a potent and selective agonist of GPR119 that shows similar potency to oleoyl ethanolamide (OEA) at both recombinant mouse and human GPR119 receptors, exhibiting EC50 values of 8.4 and 7.9 µM, respectively (EC50 values for OEA are 3.2 and 2.9 µM, respectively).{14046} These data suggest that PSN375963 may be useful as a therapeutic agent for the treatment of obesity.  

     

    Brand:
    Cayman
    SKU:10008593 - 10 mg

    Available on backorder

  • GPR119 (previously designated SNORF25) is an orphan G protein-coupled receptor expressed predominantly in the pancreas and gastrointestinal tract in humans and in the brain, pancreas, and gastrointestinal tract in rodents. It mediates a reduction in food intake and body weight gain in rats upon treatment with oleoyl ethanolamide (OEA), an endogenous, potent agonist for PPARα.{11423,14046} PSN375963 is a potent and selective agonist of GPR119 that shows similar potency to oleoyl ethanolamide (OEA) at both recombinant mouse and human GPR119 receptors, exhibiting EC50 values of 8.4 and 7.9 µM, respectively (EC50 values for OEA are 3.2 and 2.9 µM, respectively).{14046} These data suggest that PSN375963 may be useful as a therapeutic agent for the treatment of obesity.  

     

    Brand:
    Cayman
    SKU:10008593 - 25 mg

    Available on backorder